Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 802

1.

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.

Komura K, Fujiwara Y, Uchimoto T, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

J Clin Med. 2019 Aug 19;8(8). pii: E1251. doi: 10.3390/jcm8081251.

2.

The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.

Komura K, Hashimoto T, Tsujino T, Muraoka R, Tsutsumi T, Satake N, Matsunaga T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Uehara H, Tanaka T, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.

Ann Surg Oncol. 2019 Sep;26(9):2994-3004. doi: 10.1245/s10434-019-07530-5. Epub 2019 Jun 25.

PMID:
31240592
3.

Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.

Tamura K, Nukiwa T, Gemma A, Yamamoto N, Mizushima M, Ochai K, Ikeda R, Azuma H, Nakanishi Y.

Int J Clin Oncol. 2019 Sep;24(9):1169. doi: 10.1007/s10147-019-01488-w.

PMID:
31240497
4.

Characterization of a New Saccharomyces cerevisiae Isolated From Hibiscus Flower and Its Mutant With L-Leucine Accumulation for Awamori Brewing.

Abe T, Toyokawa Y, Sugimoto Y, Azuma H, Tsukahara K, Nasuno R, Watanabe D, Tsukahara M, Takagi H.

Front Genet. 2019 May 28;10:490. doi: 10.3389/fgene.2019.00490. eCollection 2019.

5.

Nonuniform sampling pitch acquisition method in myocardial single-photon emission computed tomography.

Shirakawa S, Tsukamoto K, Azuma H, Nakashima K, Tsujimoto M, Takano K, Yamada M.

Nucl Med Commun. 2019 Aug;40(8):792-801. doi: 10.1097/MNM.0000000000001036.

PMID:
31107829
6.

Changes of T-cell immunity over a lifetime.

Nian Y, Minami K, Maenesono R, Iske J, Yang J, Azuma H, ElKhal A, Tullius SG.

Transplantation. 2019 May 15. doi: 10.1097/TP.0000000000002786. [Epub ahead of print]

PMID:
31107822
7.

MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.

Tsujino T, Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y.

Cancer Sci. 2019 Jul;110(7):2189-2199. doi: 10.1111/cas.14035. Epub 2019 May 27.

8.

C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan.

Tsujino T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsutsumi T, Yoshikawa Y, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.

Urol Oncol. 2019 Apr 30. pii: S1078-1439(19)30135-8. doi: 10.1016/j.urolonc.2019.04.002. [Epub ahead of print]

PMID:
31053528
9.

Severe gastrointestinal involvement predictive score in IgA vasculitis is also a risk factor for nephritis being varied depending on their ages of onset.

Nagamori T, Takahashi H, Yoshida Y, Oka H, Yamamoto S, Manabe H, Taketazu G, Mukai T, Sakata H, Oki J, Azuma H.

J Paediatr Child Health. 2019 May;55(5):609-610. doi: 10.1111/jpc.14442. No abstract available.

PMID:
31017368
10.

Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.

Tamura K, Nukiwa T, Gemma A, Yamamoto N, Mizushima M, Ochai K, Ikeda R, Azuma H, Nakanishi Y.

Int J Clin Oncol. 2019 Aug;24(8):917-926. doi: 10.1007/s10147-019-01439-5. Epub 2019 Apr 5. Erratum in: Int J Clin Oncol. 2019 Jun 25;:.

11.

A case of malignant solitary fibrous tumor of the prostatic urethra.

Tanaka Y, Nakamoto A, Inada Y, Narumi Y, Hirose Y, Azuma H.

BJR Case Rep. 2018 Dec;4(4):20180034. doi: 10.1259/bjrcr.20180034. Epub 2018 Jun 1.

12.

Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo.

Takai T, Tsujino T, Yoshikawa Y, Inamoto T, Sugito N, Kuranaga Y, Heishima K, Soga T, Hayashi K, Miyata K, Kataoka K, Azuma H, Akao Y.

Mol Ther. 2019 May 8;27(5):1017-1027. doi: 10.1016/j.ymthe.2019.03.004. Epub 2019 Mar 13.

13.

Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical Treatment.

Yoshikawa Y, Taniguchi K, Tsujino T, Heishima K, Inamoto T, Takai T, Minami K, Azuma H, Miyata K, Hayashi K, Kataoka K, Akao Y.

Mol Ther Methods Clin Dev. 2019 Feb 20;13:290-302. doi: 10.1016/j.omtm.2019.02.005. eCollection 2019 Jun 14.

14.

Comparison of acute vertigo diagnosis and treatment practices between otolaryngologists and non-otolaryngologists: A multicenter scenario-based survey.

Numata K, Shiga T, Omura K, Umibe A, Hiraoka E, Yamanaka S, Azuma H, Yamada Y, Kobayashi D.

PLoS One. 2019 Mar 7;14(3):e0213196. doi: 10.1371/journal.pone.0213196. eCollection 2019.

15.

Langerhans cell histiocytosis isolated to the thymus in a 7-month-old infant.

Matsumoto N, Toriumi N, Sarashina T, Hatakeyama N, Azuma H.

Pediatr Int. 2019 Feb;61(2):205-206. doi: 10.1111/ped.13749. Epub 2019 Feb 15. No abstract available.

PMID:
30767312
16.

Pulmonary Hemodynamic Changes with Nitric Oxide or Oxygen in a Patient with Asplenia, Single Right Ventricle, and Total Anomalous Pulmonary Venous Connection after Fontan Procedure.

Oka H, Nakau K, Kajihama A, Sugimoto M, Azuma H.

Case Rep Cardiol. 2018 Nov 25;2018:3736254. doi: 10.1155/2018/3736254. eCollection 2018.

17.

Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan.

Hirano H, Matsunaga T, Maenosono R, Taniguchi S, Uehara H, Nomi H, Kano Y, Fujiwara Y, Ichihashi A, Kobayashi D, Tsutsumi T, Komura K, Ibuki N, Inamoto T, Matsumura H, Ashida A, Azuma H.

Transplant Proc. 2018 Dec;50(10):3255-3257. doi: 10.1016/j.transproceed.2018.04.064. Epub 2018 May 4.

PMID:
30577194
18.

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

Ther Adv Urol. 2018 Nov 11;10(12):403-410. doi: 10.1177/1756287218811050. eCollection 2018 Dec.

19.

Application of Perfusate With Human-Derived Oxygen Carrier Solution Under Subnormothermic Machine Perfusion for Donation After Cardiac Death Liver Grafts in Pigs.

Shonaka T, Matsuno N, Obara H, Yoshikawa R, Nishikawa Y, Gouchi M, Otani M, Takahashi H, Azuma H, Sakai H, Furukawa H.

Transplant Proc. 2018 Nov;50(9):2821-2825. doi: 10.1016/j.transproceed.2018.02.184. Epub 2018 Mar 20.

PMID:
30401404
20.

Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.

Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Komura K, Uehara H, Minami K, Yamamoto K, Narumi Y.

Int J Oncol. 2019 Jan;54(1):167-176. doi: 10.3892/ijo.2018.4619. Epub 2018 Nov 2.

PMID:
30387836
21.

Editorial Comment from Dr Inamoto and Dr Azuma to Preclinical orthotopic xenograft model of renal pelvis cancer in which cancer growth could be traced by an in vivo imaging system.

Inamoto T, Azuma H.

Int J Urol. 2019 Jan;26(1):140-141. doi: 10.1111/iju.13836. Epub 2018 Oct 25. No abstract available.

PMID:
30362179
22.

Safety of Elderly Living Kidney Donors: 2 Cases of Donors Older Than 80 Years: A Case Report.

Hirano H, Maenosono R, Matsunaga T, Uehara H, Nomi H, Ichihashi A, Kobayashi D, Taniguchi S, Tsutsumi T, Tsujino T, Komura K, Ibuki N, Inamoto T, Azuma H.

Transplant Proc. 2018 Oct;50(8):2569-2571. doi: 10.1016/j.transproceed.2018.03.093. Epub 2018 Mar 19.

PMID:
30316400
23.

Are there any metastases to the chest in non-muscle-invasive bladder cancer patients on follow-up computed tomography?

Juri H, Koyama M, Azuma H, Narumi Y.

Int Urol Nephrol. 2018 Oct;50(10):1771-1778. doi: 10.1007/s11255-018-1952-4. Epub 2018 Aug 16.

PMID:
30117014
24.

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.

Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H.

Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018.

25.

Detectability of residual invasive bladder cancer in delayed 18F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.

Higashiyama A, Komori T, Juri H, Inada Y, Azuma H, Narumi Y.

Ann Nucl Med. 2018 Oct;32(8):561-567. doi: 10.1007/s12149-018-1280-x. Epub 2018 Jul 16.

PMID:
30014439
26.

The Expression of MAS1, an Angiotensin (1-7) Receptor, in the Eutopic Proliferative Endometria of Endometriosis Patients.

Nakajima T, Chishima F, Nakao T, Hayashi C, Kasuga A, Shinya K, Nakayama T, Azuma H, Ichikawa G, Komatsu A, Yamamoto T, Kawana K.

Gynecol Obstet Invest. 2018;83(6):600-607. doi: 10.1159/000490561. Epub 2018 Jul 6.

PMID:
29982252
27.

ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.

Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW.

J Clin Invest. 2018 Jul 2;128(7):2979-2995. doi: 10.1172/JCI96769. Epub 2018 Jun 4.

28.

Characterization of human decidual mast cells and establishment of a culture system.

Matsuno T, Toyoshima S, Sakamoto-Sasaki T, Kashiwakura JI, Matsuda A, Watanabe Y, Azuma H, Kawana K, Yamamoto T, Okayama Y.

Allergol Int. 2018 Sep;67S:S18-S24. doi: 10.1016/j.alit.2018.05.001. Epub 2018 May 18.

29.

Calreticulin and integrin alpha dissociation induces anti-inflammatory programming in animal models of inflammatory bowel disease.

Ohkuro M, Kim JD, Kuboi Y, Hayashi Y, Mizukami H, Kobayashi-Kuramochi H, Muramoto K, Shirato M, Michikawa-Tanaka F, Moriya J, Kozaki T, Takase K, Chiba K, Agarwala KL, Kimura T, Kotake M, Kawahara T, Yoneda N, Hirota S, Azuma H, Ozasa-Komura N, Ohashi Y, Muratani M, Kimura K, Hishinuma I, Fukamizu A.

Nat Commun. 2018 May 17;9(1):1982. doi: 10.1038/s41467-018-04420-4.

30.

Assessment of Potential Renal Dysfunction in Patients with Congenital Heart Disease after Biventricular Repair.

Oka H, Nakau K, Kajihama A, Azuma H.

Korean Circ J. 2018 May;48(5):418-426. doi: 10.4070/kcj.2017.0017. Epub 2018 Apr 2.

31.

A case of primary familial congenital polycythemia with a novel EPOR mutation: possible spontaneous remission/alleviation by menstrual bleeding.

Toriumi N, Kaneda M, Hatakeyama N, Manabe H, Okajima K, Sakurai Y, Yamamoto M, Sarashina T, Ikuta K, Azuma H.

Int J Hematol. 2018 Sep;108(3):339-343. doi: 10.1007/s12185-018-2435-1. Epub 2018 Apr 5.

PMID:
29623657
32.

Displaced anterior pelvic fracture on initial pelvic radiography predicts massive hemorrhage.

Tanizaki S, Maeda S, Sera M, Nagai H, Nakanishi T, Hayashi M, Azuma H, Kano KI, Watanabe H, Ishida H.

Am J Emerg Med. 2018 Dec;36(12):2172-2176. doi: 10.1016/j.ajem.2018.03.058. Epub 2018 Mar 21.

PMID:
29602669
33.

Mast cells regulate CD4+ T-cell differentiation in the absence of antigen presentation.

Rodriguez Cetina Biefer H, Heinbokel T, Uehara H, Camacho V, Minami K, Nian Y, Koduru S, El Fatimy R, Ghiran I, Trachtenberg AJ, de la Fuente MA, Azuma H, Akbari O, Tullius SG, Vasudevan A, Elkhal A.

J Allergy Clin Immunol. 2018 Dec;142(6):1894-1908.e7. doi: 10.1016/j.jaci.2018.01.038. Epub 2018 Feb 20.

34.

Corrigendum to "Flow cytometric quantitation of platelet phagocytosis by monocytes using a pH-sensitive dye, pHrodo-SE" [Journal of Immunological Methods 447 (2017) 57-64].

Takahashi D, Fujihara M, Miyazaki T, Matsubayashi K, Sato S, Azuma H, Kato T, Kino S, Ikeda H, Takamoto S, Sato N, Torigoe T.

J Immunol Methods. 2018 Mar;454:89. doi: 10.1016/j.jim.2018.02.001.

PMID:
29455735
35.

Dual Gas Treatment With Hydrogen and Carbon Monoxide Attenuates Oxidative Stress and Protects From Renal Ischemia-Reperfusion Injury.

Nishida T, Hayashi T, Inamoto T, Kato R, Ibuki N, Takahara K, Takai T, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Hirano H, Nomi H, Okada Y, Azuma H.

Transplant Proc. 2018 Jan - Feb;50(1):250-258. doi: 10.1016/j.transproceed.2017.12.014.

PMID:
29407319
36.

[A Case of Retroperitoneal Teratoma Difficult to Distinguish from Adrenal Tumor].

Maenosono R, Saito K, Ibuki N, Takahara K, Inamoto T, Nomi H, Azuma H.

Hinyokika Kiyo. 2017 Dec;63(12):525-528. doi: 10.14989/ActaUrolJap_63_12_525. Review. Japanese.

37.

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.

Inamoto T, Matsuyama H, Sakano S, Ibuki N, Takahara K, Komura K, Takai T, Tsujino T, Yoshikawa Y, Minami K, Nagao K, Inoue R, Azuma H.

Oncotarget. 2017 Nov 23;8(68):113248-113257. doi: 10.18632/oncotarget.22641. eCollection 2017 Dec 22.

38.

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.

Tsujino T, Komura K, Ichihashi A, Tsutsumi T, Matsunaga T, Yoshikawa Y, Maenosono R, Okita K, Takai T, Oide R, Minami K, Uehara H, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

Oncotarget. 2017 Nov 25;8(66):110311-110325. doi: 10.18632/oncotarget.22688. eCollection 2017 Dec 15.

39.

Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Miyake M, Tatsumi Y, Matsumoto H, Nagao K, Matsuyama H, Inamoto T, Azuma H, Yasumoto H, Shiina H, Fujimoto K; Nishinihon Uro-Oncology Collaborative Group.

BJU Int. 2018 May;121(5):764-773. doi: 10.1111/bju.14111. Epub 2018 Jan 21.

40.

Congenital basal meningoceles with different outcomes: a case series.

Okano S, Tanaka R, Okayama A, Tsuchida E, Nohara F, Suzuki N, Okamoto T, Nagaya K, Takahashi S, Azuma H.

J Med Case Rep. 2017 Dec 27;11(1):359. doi: 10.1186/s13256-017-1497-7.

41.

Current treatment strategies for advanced prostate cancer.

Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW.

Int J Urol. 2018 Mar;25(3):220-231. doi: 10.1111/iju.13512. Epub 2017 Dec 20. Review.

42.

Evolution into moyamoya disease in an infant with internal carotid artery aneurysms.

Tanaka R, Takahashi S, Okano S, Okayama A, Suzuki N, Kure S, Azuma H.

eNeurologicalSci. 2017 Jan 31;6:80-82. doi: 10.1016/j.ensci.2017.01.002. eCollection 2017 Mar.

43.

Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.

Fujita K, Taneishi K, Inamoto T, Ishizuya Y, Takada S, Tsujihata M, Tanigawa G, Minato N, Nakazawa S, Takada T, Iwanishi T, Uemura M, Okuno Y, Azuma H, Norio N.

BMC Urol. 2017 Dec 1;17(1):110. doi: 10.1186/s12894-017-0305-4.

44.

Can bladder preservation therapy come to the center stage?

Inamoto T, Ibuki N, Komura K, Juri H, Yamamoto K, Yamamoto K, Fujita K, Nonomura N, Narumi Y, Azuma H.

Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23. Review.

45.

Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

J Urol. 2018 Apr;199(4):933-939. doi: 10.1016/j.juro.2017.10.019. Epub 2017 Oct 14.

PMID:
29037861
46.

Novel splice site mutation in GATA3 in a patient with HDR syndrome.

Matsuo K, Kobayashi A, Tanahashi Y, Maruyama S, Niitsu Y, Katsuta H, Furuya A, Suzuki S, Kawamura M, Azuma H.

Clin Pediatr Endocrinol. 2017;26(4):271-273. doi: 10.1297/cpe.26.271. Epub 2017 Sep 28. No abstract available.

47.

S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.

Takemura S, Azuma H, Osada-Oka M, Kubo S, Shibata T, Minamiyama Y.

Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G150-G163. doi: 10.1152/ajpgi.00023.2017. Epub 2017 Sep 28.

48.
49.

Recall features and allorecognition in innate immunity.

Uehara H, Minami K, Quante M, Nian Y, Heinbokel T, Azuma H, Khal AE, Tullius SG.

Transpl Int. 2018 Jan;31(1):6-13. doi: 10.1111/tri.13073. Epub 2017 Oct 20. Review.

50.

Rapamycin Prolongs Graft Survival and Induces CD4+IFN-γ+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice.

Quante M, Heinbokel T, Edtinger K, Minami K, Uehara H, Nian Y, Azuma H, Abdi R, Elkhal A, Tullius SG.

Transplantation. 2018 Jan;102(1):59-69. doi: 10.1097/TP.0000000000001902.

Supplemental Content

Support Center